Monitoring neoadjuvant therapy responses in rectal cancer using multimodal nonlinear optical microscopy

• Published in: Oncotarget 2017-12, Vol.8 (63), p.107323-107333
• Main Authors: Li, Lian-Huang, Chen, Zhi-Fen, Wang, Xing-Fu, Liu, Xing, Jiang, Wei-Zhong, Zhuo, Shuang-Mu, Jiang, Li-Wei, Guan, Guo-Xian, Chen, Jian-Xin
• Format: Article
• Language: English
• Subjects: Clinical Research Paper
• ISSN: 1949-2553; 1949-2553
• DOI: 10.18632/oncotarget.22366

Most patients with rectal cancer have a better prognosis after receiving neoadjuvant therapy because of its remarkable curative effect. However, no device delivers real-time histopathologic information on treatment response to help clinicians tailor individual therapeutic strategies. We assessed the potential of multimodal nonlinear optical microscopy to monitor therapeutic responses, including tumoral and stromal responses. We found that two-photon excited fluorescence imaging can, without labeling, identify colloid response, inflammatory cell infiltration, vascular proliferation, and tumor regression. It can also directly detect rare residual tumor cells, which may be helpful for distinguishing tumor shrinkage from tumor fragmentation. In addition, second harmonic generation imaging shows the ability to monitor three types of fibrotic responses: mature, intermediate, and immature. We also determined nonlinear spectra, collagen density, and collagen orientation indexes to quantitatively analyze the histopathologic changes induced by neoadjuvant therapy in rectal cancer. Our work demonstrates that nonlinear optical microscopy has the potential to become a label-free, real-time, medical imaging technique and provides the groundwork for further exploration into the application of nonlinear optical microscopy in a clinical setting.